Ciftci K, Levy RJ. Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts. Int J Pharm 2001, 218, 81-92.

Curiel DT, Agarwal S, Wagner E, Cotten M. Adenovirus enhancement of transferrin-polysine-mediated gene delivery. Proc Natl Acad Sci USA 1991, 88, 8850-8854.

Cotten M, Wagner E, Zatloukal K, Phillips S, Curiel DT, Birsnstiel ML. High-efficiency receptor-mediated delivery of small and large (48-kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci USA 1992, 89, 6094-6098. Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 1994, 269, 12918-12924.

Subramanian A, Ma H, Dahl KN, Zhu J, Diamond SL. Adenovirus or HA-2 fusogenic peptide-assisted lipofection increases cytoplasmic levels of plasmid in nondividing endothelium with little enhancement of transgene expression. J Gene Med 2002, 4, 75-83.

Ogris M, Carlisle RC, Bettinger T, Seymour LW. Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors. J Biol Chem 2001, 276, 47550-47555.

Cheung CY, Murthy N, Stayton PS, Hoffman AS. A pH-sensitive polymer that enhances cationic lipid-mediated gene transfer. Bioconjung Chem 2001, 12, 906-910.

Pack DW, Putnam D, Langer R. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol Bioeng 2000, 67, 217-223. Murthy N, Robichaud JR, Tirrell DA, Stayton PS, Hoffman AS. The design and synthesis of polymers for eukaryotic membrane disruption. J Control Release 1999, 61, 137-143.

Lukacs GL, Haggie P, Seksek O, Lechardeur D, Freedman N, Verkman AS. Size-dependent DNA mobility in cytoplasm and nucleus. J Biol Chem 2000, 275, 1625-1629.

Hasegawa S, Hirashima N, Nakanishi M. Microtubule involvement in the intracellular dynamics for gene transfection mediated by cationic liposomes. Gene Ther 2001, 8, 1669-1673.

Godbey WT, Barry MA, Saggau P, Wu KK, Mikos AG. Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res 2000, 51, 321-328.

Gonzalez H, Hwang SJ, Davis ME. New class of polymers for the delivery of macromolecular therapeutics. Bioconjugate Chemistry 1999, 10, 1068-1074. Oh YK, Swanson JA. Different fates of phagocytosed particles after delivery into macrophage lysosomes. J Cell Biol 1996, 132, 585-593.

Tachibana R, Harashima H, Shinohara Y, Kiwada H. Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. Adv Drug Deliv Rev 2001, 52, 219-226.

Nakanishi M, Akuta T, Nagoshi E, Eguchi A, Mizuguchi H, Senda T. Nuclear targeting of DNA. Eur J Pharm Sci 2001, 13, 17-24.

Pouton CW. Nuclear import of polypeptides, polynucleotides and supramolecular complexes. Adv Drug Deliv Rev 1998, 34, 51-64.

Goldberg MW, Allen TD. High-resolution scanning electron microscopy of the nuclear envelope: demonstration of a new, regular, fibrous lattice attached to the baskets of the nucleoplasmic face of the nuclear pores. J Cell Biol 1992, 119, 1429-1440.

Zanta MA, Belguise-Valladier P, Behr JP. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA 1999, 96, 91-96.

Carlisle RC, Bettinger T, Ogris M, Hale S, Mautner V, Seymour LW. Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors. Mol Ther 2001, 4, 473-483. Rebuffat A, Bernasconi A, Ceppi M, Wehrli H, Verca SB, Ibrahim M, Frey BM, Frey FJ, Rusconi S. Selective enhancement of gene transfer by steroid-mediated gene delivery. Nat Biotechnol 2001, 19, 1155-1161.

Brunner S, Sauer T, Carotta S, Cotten M, Saltik M, Wagner E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther 2000, 7, 401-407.

Schaffer DV, Fidelman NA, Dan N, Lauffenburger DA. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng

Fu J, Krauland E, Har-el Y, Hanes J. Biodegradable cationic poly(aspartic anhydride-co-ethylene glycol): Synthesis, characterization, and self-assembly with plasmid DNA, submitted to Macromolecules.

Lynn DM, Langer R. Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 2000, 122, 10761-10768.

Lim YB, Han SO, Kong HU, Lee Y, Park JS, Jeong B, Kim SW. Biodegradable polyester, poly[alpha-(4-aminobuty1)-l-glycolic acid], as a nontoxic gene carrier. Pharm Res 2000, 17, 811-816.

Kamiya H, Tsuchiya H, Yamazaki J, Harashima H. Intracellular trafficking and transgene expression of viral and nonviral gene vectors. Adv Drug Deliv Rev 2001, 52, 153-164.

Hong K, Sherley J, Lauffenburger DA. Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector. Biomol Eng

Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta 2001, 1514, 51-64.

Labat-Moleur F, Steffan AM, Brisson C, Perron H, Feugeas O, Furstenberger P, Oberling F, Brambilla E, Behr JP. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther 1996, 3, 1010-1017. Briane D, Lesage D, Cao A, Coudert R, Lievre N, Salzmann JL, Taillandier E. Cellular pathway of plasmids vectorized by cholesterol-based cationic liposomes. J Histochem Cytochem 2002, 50, 983-991.

Lappalainen K, Miettinen R, Kellokoski J, Jaaskelainen I, Syrjanen S. Intracellular distribution of oligonucleotides delivered by cationic liposomes: light and electron microscopic study. J Histochem Cytochem 1997, 45, 265-274. El Ouahabi A, Thiry M, Schiffmann S, Fuks R, Nguyen-Tran H, Ruysschaert JM, Vandenbranden M. Intracellular visualization of BrdU-labeled plasmid DNA/ca-tionic liposome complexes. J Histochem Cytochem 1999, 47, 1159-1166. Landahl H. On the removal of air-borne droplets by the human respiratory tract I. The lung. Bull Math Biophys 1950, 12, 43-56.

Schulz H. Mechanisms and factors affecting intrapulmonary particle deposition: implications for efficient inhalation therapies. Pharm Sci Technol Today 1998, 1, 336-344.

Crowder TM, Rosati JA, Schroeter JD, Hickey AJ, Martonen TB. Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development. Pharm Res 2002, 19, 239-245.

Lippmann M, Albert RE. The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract. Am Ind Hyg Assoc J 1969, 30, 257-275.

Lippmann M. Recent advances in respiratory tract particle deposition. In Occupational and Industrial Hygiene: Concepts and Methods; Esmen NA, Mehlman MA, eds. Princeton Scientific: Princeton, NJ, 1984; Vol. VIII, 75-103. Heyder J, Gebhart J, Rudolf G, Schiller CF, Stahlhofen W. Deposition of particles in the human respiratory tract in the size range 0.005-15 mm. J Aerosol Sci 1986, 17, 811-825.

Snipes MB. Biokinetics of inhaled radionuclides. In Internal Radiation Dosimetry; Raabe OG, ed. Medical Physics: Madison, WI, 1994; 181-204. Task Group on Lung Dynamics. Deposition and retention models for internal dosimetry of the human respiratory tract. Health Phys 1966, 12, 173-207. Darquenne C, Brand P, Heyder J, Paiva M. Aerosol dispersion in human lung: comparison between numerical simulations and experiments for bolus tests. J Appl Physiol 1997, 83, 966-974.

Fu J, Fiegel J, Krauland E, Hanes J. New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 2002, 23, 4425-4433. pulmonary drug delivery, Biomaterials, Published Online, June 18, 2002. Newman SP, Woodman G, Clarke SW. Deposition of carbenicillin aerosol in cystic fibrosis: effects of nebulizer system and breathing pattern. Thorax 1988, 43, 318-322.

Regnis JA, Robinson M, Bailey DL, Cook P, Hooper P, Chan HK, Gonda I, Bautovich G, Bye PT. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med 1994, 150, 66-71. Hinds WC. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles; 2nd ed; Wiley: New York, 1999.

Stoeber W. Dynamic shape factors of nonspherical aerosol particles. In Assessment of Airborne Particles; Mercer TT, Morrow PE, Stoeber W, eds. Charles C Thomas: Springfield, IL, 1972; 249-289.

Timbrell V. Deposition and Retention of Fibers in the Human-Lung. Ann Occup Hyg 1982, 26, 347-369.

Asgharian B, Yu CP. Deposition of inhaled fibrous particles in the human lung. J Aerosol Med 1988, 1, 37-50.

Timbrell V. Human exposure to asbestos: dust controls and standards. The inhalation of fibrous dusts. Ann NY Acad Sci 1965, 132, 255-273. Gonda I. Targeting by deposition. In Pharmaceutical Inhalation Aerosol Technology; Hickey AJ, ed. Marcel Dekker: New York, 1992; 61-82. Schultz H, Brand P, Heyder J. Particle Deposition in the Respiratory Tract. Particle-Lung Interactions; Marcel Dekker: New York, 2000; 229-290. Raabe OG. Aerosol aerodynamic size conventions for inertial sampler calibration. J Air Poll Control Assoc 1976, 26, 856-860.

Einstein A. On the kinetic molecular theory of thermal movements of particles suspended in a quiescent fluid. Ann Phys 1905, 17, 549-560. Lippmann, M. Regional deposition of particles in the human respiratory tract. In: D.H.K. Lee, H.L. Falk, S.O. Murphy, S.R. Geiger (eds.), Handbook of Physiology, Reaction to Environmental Agents. Bethesda, MD: American Physiological Society, 1977.

Martonen TB, Katz IM. Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters. Pharm Res 1993, 10, 871-878. Gebhart J, Heyder J, Stahlhofen W. Use of aerosols to estimate pulmonary air-space dimensions. J Appl Physiol 1981, 51, 465-476.

Palmes ED, Wang CS, Goldring RM, Altshuler B. Effect of depth of inhalation on aerosol persistence during breath holding. J Appl Physiol 1973, 34, 356-360. Kim CS, Eldridge MA. Aerosol deposition in the airway model with excessive mucus secretions. J Appl Physiol 1985, 59, 1766-1772.

Smaldone GC, Messina MS. Enhancement of particle deposition by flow-limiting segments in humans. J Appl Physiol 1985, 59, 509-514.

Anderson PJ, Blanchard JD, Brain JD, Feldman HA, McNamara JJ, Heyder J. Effect of cystic fibrosis on inhaled aerosol boluses. Am Rev Respir Dis 1989, 140, 1317- 1324.

Kavanaugh RE, Unadkat JD, Smith AL. Drug disposition in cystic fibrosis. In Cystic Fibrosis; Davis PB, ed. McGraw-Hill: New York, 1993; 91-136. Martonen T, Katz I, Cress W. Aerosol deposition as a function of airway disease: cystic fibrosis. Pharm Res 1995, 12, 96-102.

Brand P, Meyer T, Sommerer K, Weber N, Scheuch G. Alveolar deposition of monodisperse aerosol particles in the lung of patients with chronic obstructive pulmonary disease. Exp Lung Res 2002, 28, 39-54.

Gagnadoux F, Diot P, Marchand S, Thompson R, Dieckman K, Lemarie E, Varaigne F, Maurage C, Baulieu JL, Rolland JC. Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer. Rev Mal Respir 1996, 13, 55-60.

Kuni CC, Budd JR, Regelmann WE, Ducret RP, Boudreau RJ. Comparison of Tc-99m DTPA aerosol ventilation studies with pulmonary function testing in cystic fibrosis. Clin Nucl Med 1993, 18, 15-18.

Laube BL, Chang DY, Blask AN, Rosenstein BJ. Radioaerosol assessment of lung improvement in cystic fibrosis patients treated for acute pulmonary exacerbations. Chest 1992, 101, 1302-1308.

Marshall LM, Francis PW, Khafagi FA. Aerosol deposition in cystic fibrosis using an aerosol conservation device and a conventional jet nebulizer. J Paediatr Child Health 1994, 30, 65-67.

Podczeck F. Particle-Particle Adhesion in Pharmaceutical Powder Handling; Imperial College Press: London, 1998.

Zeng XM, Martin GP, Tee SK, Marriott C. The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro. Int J Pharm 1998, 176, 99-110.

Tee SK, Marriott C, Zeng XM, Martin GP. The use of different sugars as fine and coarse carriers for aerosolized salbutamol sulphate. Int J Pharm 2000, 208, 111-123.

French DL, Edwards DA, Niven RW. The influence of formulations on emission, deaggregation, and deposition of dry powders for inhalation. J Aerosol Sci 1996, 27, 769-783.

Staniforth JN. Particle interactions in dry-powder formulation of aerocolloida suspensions. In: Proceedings of the Second Respiratory Drug Delivery Symposium, College of Pharmacy, The University of Kentucky, Keystone, CO, 1990, pp. 26-30.

Hickey AJ, Concessio NM, Van Oort MM, Platz RM. Factors influencing the dispersion of dry powders as aerosols, Pharm Tech 58 + , 1994. Gotoh K, Masuda H, Higashitani K. Powder Technology Handbook; 2nd ed; Marcel Dekker: New York, 1997.

Visser J. Van der Waals and other cohesive forces affecting powder fluidization. Powder Technol 1989, 58, 1-10.

Edwards DA, Ben-Jebria A, Langer R. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol 1998, 85, 379-385. Hickey AJ. Inhalation Aerosols; Marcel Dekker: New York, 1996; Vol. 96. Bennett FS, Carter PA, Rowley G, Dandiker Y. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles. Drug Dev Ind Pharm 1999, 25, 99-103.

Marlow WH. Survey of aerosol interactive forces. In Aerosol Microphysics I: Particle Interaction; Marlow WH, ed. McGraw-Hill: New York, 1980; 116-156. Khilnani A. Cleaning semiconductor surfaces: facts and foibles. In Particles on Surfaces 1: Detection, Adhesion, and Removal; Mittal KL, ed. Plenum Press: New York, 1988; 17-35.

Zimon AD. Adhesion of Dust and Powder; 2nd ed; Consultants Bureau: New York, 1982.

Podczeck F, Newton JM, James MB. Variations in the adhesion force between a drug and carrier particles as a result of changes in the relative humidity of the air. Int J Pharm 1997, 149, 151-160.

Finlay WH. The Mechanisms of Inhaled Pharmaceutical Aerosols; Academic Press: San Diego, 2001; 221-276.

Li W-I, Perzl M, Heyder J, Langer R, Brain JD, Englmeier K-H, Niven RW, Edwards DA. Aerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavities. J Aerosol Sci 1996, 27, 1269-1286. Timsina MP, Martin GP, Marriott C, Ganderton D, Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm 1994, 101, 1-13. Neumann BS. The flow properties of powders. In Advances in Pharmaceutical Science; Bean HS, Beckett AH, Carless JE, eds. Academic Press: London, 1967; Vol. 2, 181-221.

Edwards DA, Hanes J, Caponetti G, Hrkach J, BenJebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R. Large porous particles for pulmonary drug delivery. Science 1997, 276, 1868-1871.

Batycky RP, Hanes J, Langer R, Edwards DA. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci 1997, 86, 1464-1477.

Hirst PH, Pitcairn GR, Weers JG, Tarara TE, Clark AR, Dellamary LA, Hall G, Shorr J, Newman SP. In vivo lung deposition of hollow porous particles from a pressurized metered-dose inhaler. Pharm Res 2002, 19, 258-264. Duddu SP, Sisk SA, Walter YH, Tarara TE, Trimble KR, Clark AR, Eldon MA, Elton RC, Pickford M, Hirst PH, Newman SP, Weers JG. Improved lung delivery from a passive dry powder inhaler using an engineered PulmoSphere powder. Pharm Res 2002, 19, 689-695.

Podczeck F, Newton JM, James MB. The influence of physical properties of materials in contact on the adhesion strength of particles of salmeterol base and salmeterol salts to various substrate materials. J Adhesion Sci Technol 1996, 10, 257-268.

Maugis D. On the contact and adhesion of rough surfaces. J Adhesion Sci Technol 1996, 10, 161-175.

Podczeck F, Newton JM, James MB. The adhesion force of micronized Salmeterol Xinafoate particles to pharmaceutically relevant surface materials. J Phys D: Appl Phys 1996, 29, 1878-1884.

Tabor D. Surface forces and surface interactions. J Colloid Interfac Sci 1977, 58, 2-13.

Broday DM, Georgopoulos PG. Growth and deposition of hygroscopic particulate matter in the human lungs. Aerosol Sci Technol 2001, 34, 144-159.

Peng CG, Chow AHL, Chan CK. Study of the hygroscopic properties of selected pharmaceutical aerosols using single particle levitation. Pharm Res 2000, 17,

Dealing With Asthma Naturally

Dealing With Asthma Naturally

Do You Suffer From ASTHMA Chronic asthma is a paralyzing, suffocating and socially isolating condition that can cause anxiety that can trigger even more attacks. Before you know it you are caught in a vicious cycle Put an end to the dependence on inhalers, buying expensive prescription drugs and avoidance of allergenic situations and animals. Get control of your life again and Deal With Asthma Naturally

Get My Free Ebook

Post a comment